Henter pris…
Værdiansættelse (TTM)
Kursudvikling
Kun 72 handelsdage i databasen. Viser al tilgængelig historik.
Data-readiness
10 års prishistorik er idealet for høj confidence.
- Prishistorik
- 0,3 år
- Pris-dage
- 72
- Årsregnskaber
- 4
- Peers
- 0/0
- Valuation
- 5/6
- Fundamentals
- 8/8
- Datovindue
- 2026-02-17 til 2026-05-29
Blokkere
- Raw confidence is below the 0.95 high-confidence guardrail.
Mangler før højere confidence
- Mangler ca. 9,7 års prishistorik før ideal/full.
- Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
- Hent flere årlige SEC-fundamentals for historisk kvalitet.
- Kør compute-multiples for manglende valuation metrics.
Seneste assessment
BTSG vurderet 2026-06-10
Raw confidence is below the 0.95 high-confidence guardrail.
Stores exit-aware fields without issuing sell scores yet.
Current drawdown: Future exit logic can use drawdown from recent high.
Trend break: Future exit logic can use moving-average trend breaks.
Compares price paid with earnings, cash-generation proxies and sales.
P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.
Earnings yield: Earnings yield is the inverse P/E lens.
Checks trend, momentum and current damage from recent highs.
6M momentum: Positive medium-term momentum confirms sponsorship.
Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.
Checks whether the assessment has enough recent price, fundamental and valuation data.
Price history depth: More than one trading year gives the technical pillar enough context.
Latest price freshness: Latest live or EOD price should be recent.
Treats macro as context, not a standalone trading instruction.
VIX: Normal volatility is supportive; panic or complacency is less clean.
10Y-2Y curve: Positive yield curve lowers recession stress.
Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.
Revenue growth 3Y: Sustained top-line growth supports durable compounding.
Gross margin: High gross margin gives room for reinvestment and downturns.
Adds relative context when sector peers have comparable data.
Peer count: Peer context is only scored when comparable data exists.
P/E vs peers: Own P/E 35.7 vs peer median 12.6; premium is not clearly justified by growth or margin superiority.
Insider activity
| Dato | Person | Rolle | Type | Antal | Værdi | Kilde |
|---|---|---|---|---|---|---|
| 20.6.2026 | Greenwell Scott A. | President, PharMerica | · ANDET | -2.487 | -164.764 USD | sec |
| 11.6.2026 | Shah Nigam H. | — | · ANDET | 4.013 | — | sec |
| 5.6.2026 | Nalley Lisa A | See Remarks | ◆ OPT. | 35.000 | 222.950 USD | sec |
| 5.6.2026 | Nalley Lisa A | See Remarks | ▼ SALG | -35.000 | -2.056.250 USD | sec |
| 5.6.2026 | ROUSSEAU JON B | See Remarks | ◆ OPT. | 130.000 | 828.100 USD | sec |
| 5.6.2026 | Phipps Jennifer A | Chief Financial Officer | ◆ OPT. | 35.000 | 222.950 USD | sec |
| 5.6.2026 | — | ▼ SALG | -14.669.771 | -857.492.124 USD | sec | |
| 5.6.2026 | — | · ANDET | -324.608 | — | sec | |
| 5.6.2026 | — | ◇ GAVE | -36.927 | — | sec | |
| 5.6.2026 | ROUSSEAU JON B | See Remarks | ▼ SALG | -130.000 | -7.637.500 USD | sec |
| 5.6.2026 | Phipps Jennifer A | Chief Financial Officer | ▼ SALG | -35.000 | -2.056.250 USD | sec |
Earnings
| Quarter | Date | EPS actual | EPS est | EPS surprise | Revenue surprise | |
|---|---|---|---|---|---|---|
| 2026Q1 | 30.4.2026 | 0,39 | 0,31 | +26.1% | +26.1% | Beat |
| 2025Q4 | 30.1.2026 | 0,33 | 0,35 | -4.7% | -4.7% | Inline |
| 2025Q3 | 30.10.2025 | 0,30 | 0,26 | +13.9% | +13.9% | Beat |
| 2025Q2 | 30.7.2025 | 0,22 | 0,19 | +17.6% | +17.6% | Beat |